From: Intrathecal trastuzumab: immunotherapy improves the prognosis of leptomeningeal metastases in HER-2+ breast cancer patient
Week
1
2
3
4
Protein (g/L)
31
52a
50a
68a
RBC (/cmm3)
519
74
15
<1
WBC (/cmm3)